Findit Inc Press Releases - EIN Presswire - Press Release Distribution Service

Published on October 5, 2022 - 11:00 GMT

BioRegenx Announces Microvascular Differences Study in People with Obesity at Risk of Developing Cardiovascular Disease

CHATTANOOGA, TN, USA, October 5, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx, Inc. and its subsidiary Microvascular Health Solutions, LLC (MVHS) based in Alpine, Utah, announce a new peer-reviewed study that reveals how individuals with obesity are at risk of …

Distribution channels: Business & Economy, Culture, Society & Lifestyle ...

Published on September 28, 2022 - 11:00 GMT

BioRegenx Announces Endothelial Glycocalyx Veterinary Study of Dogs and Cats Using the Testing Device GlycoCheck

CHATTANOOGA, TN, USA, September 28, 2022 /⁨EINPresswire.com⁩/ -- Microvascular Health Solutions, LLC (MVHS), a BioRegenx subsidiary based in Alpine, Utah, announces that a new peer-reviewed study has been published using GlycoCheck, a medical testing …

Distribution channels: Business & Economy, Companies ...

Published on September 21, 2022 - 11:00 GMT

BioRegenx Announces Endothelial Glycocalyx Damage from COVID-19 Impacting Children Using the Testing Device GlycoCheck

CHATTANOOGA, TN, USA, September 21, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx, Inc. and its subsidiary Microvascular Health Solutions, LLC (MVHS) based in Alpine, Utah, announces a new peer-reviewed study analyzing the impact of COVID-19 on children. The …

Distribution channels: Business & Economy, Companies ...

Published on September 15, 2022 - 17:21 GMT

BioRegenx Announces Microvascular Dysfunction in Sepsis Study Using The Medical Testing Device GlycoCheck

CHATTANOOGA, TN, USA, September 15, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx, Inc. and its subsidiary, Microvascular Health Solutions, LLC (MVHS) based in Alpine, Utah, announces a new peer-reviewed study on microvascular dysfunction in sepsis that included …

Distribution channels: Business & Economy, Education ...

Published on September 7, 2022 - 14:20 GMT

BioRegenx Announces Study Using GlycoCheck that Links Psoriasis with Endothelial Glycocalyx Health

CHATTANOOGA, TN, USA, September 7, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx, Inc. and its subsidiary Microvascular Health Solutions, LLC (MVHS) based in Alpine, Utah, announce that a new peer-reviewed study has been published using GlycoCheck™, a FDA …

Distribution channels: Business & Economy, Companies ...

Published on August 31, 2022 - 12:00 GMT

BioRegenx Announces Cardiovascular Disease Studies Using Its Medical Testing Device GlycoCheck

CHATTANOOGA, TN, USA, August 31, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx, Inc. and its subsidiary Microvascular Health Solutions, LLC (MVHS), based in Alpine, Utah, announced that two peer-reviewed studies have been published using GlycoCheck, a medical …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on August 24, 2022 - 11:14 GMT

BioRegenx Announces Long-Haul COVID Syndrome Study Using Its’ Medical Testing Device GlycoCheck

CHATTANOOGA, TN, USA, August 24, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx, Inc. and it’s subsidiary Microvascular Health Solutions, LLC (MVHS) based in Alpine, Utah, announces a new peer-reviewed study on long-haul COVID syndrome that included the use of …

Distribution channels: Business & Economy, Companies ...

Published on August 17, 2022 - 11:00 GMT

Microvascular Health Solutions Announces High-Intensity Interval Exercise Study Using Its’ Testing Device GlycoCheck

CHATTANOOGA, TN, USA, August 17, 2022 /⁨EINPresswire.com⁩/ -- Microvascular Health Solutions, LLC (MVHS), a BioRegenx subsidiary based in Alpine, Utah, announces that a new peer-reviewed study has been published using GlycoCheck, a medical testing device, …

Distribution channels: Business & Economy, Companies ...

Published on August 9, 2022 - 18:00 GMT

Microvascular Health Solutions Announces Cellular Reconditioning for Kidney Regeneration Using GlycoCheck

CHATTANOOGA, TENNESSEE, USA, August 9, 2022 /⁨EINPresswire.com⁩/ -- Microvascular Health Solutions, LLC (MVHS), a BioRegenx subsidiary based in Alpine, Utah, announces that a new peer-reviewed study has been published using GlycoCheck, a medical testing …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...

Published on August 2, 2022 - 18:00 GMT

Oncological Study of Endothelial Glycocalyx Integrity Using Microvascular Health Solutions’ Testing Device GlycoCheck

Oncological Patient Study of Endothelial Glycocalyx Integrity Using Microvascular Health Solutions’ Medical Testing Device GlycoCheck CHATTANOOGA, TN, UNITED STATES, August 2, 2022 /⁨EINPresswire.com⁩/ -- Microvascular Health Solutions (MVHS), a BioRegenx …

Distribution channels: Business & Economy, Companies ...

Published on July 26, 2022 - 18:00 GMT

BioRegenx Announces COVID-19 and Bacterial Sepsis Study Using Microvascular Health Solutions’ Testing Device GlycoCheck

CHATTANOOGA, TN, USA, July 26, 2022 /⁨EINPresswire.com⁩/ -- BioRegenx subsidiary Microvascular Health Solutions (MVHS) announces that a new peer-reviewed study using GlycoCheck, exclusively distributed worldwide by MVHS, has been published. The study, …

Distribution channels: Banking, Finance & Investment Industry, Business & Economy ...

Published on July 19, 2022 - 17:53 GMT

BioRegenx Announces Investor Update

CHATTANOOGA, TENNESSEE, UNITED STATES, July 19, 2022 /⁨EINPresswire.com⁩/ -- CEO, William Resides announces that as of July 1st, 2022, BioRegenx has moved from due diligence to a binding letter of intent to merge with a public company. These steps also …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...